Benefits we bring to your business
We act for life science/healthcare spin out companies through to NASDAQ listed corporations. Julie also advised the Roslin Institute at the University of Edinburgh as part of a secondment. Our clients from the medtech, drug development, diagnostics and agriculture/aquaculture sectors include:
- Dxcover Limited
- Neurocentrx Pharma Limited
- Softcell Medical Limited
- Neemco Limited
- Carcinotech Ltd
- MGB Biopharma Limited
- Scotland's Rural University College (SRUC)
- Roslin Cell Therapies
We help our life science clients identify their intellectual property assets, protect these assets and advise how best to commercialise products incorporating such intellectual property rights.
Our team has extensive experience advising on angel and venture capital investment and mergers and acquisitions. We acted for Mercia Asset Management PLC on its investment in Invizius Limited, which included advising Mercia on a licence of intellectual property.
We can provide expert data protection advice in relation to medical research and clinical trials.